tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Arcellx Inc (ACLX)
NASDAQ:ACLX
US Market
ACLX
Arcellx Inc
RESEARCH TOOLSreports

Arcellx Inc (ACLX) Stock News & Sentiment

Compare
273 Followers
Positive Outlook for Arcellx Inc: Buy Rating Backed by Strategic Positioning and Promising CAR T-cell Therapy
Premium
Ratings
Positive Outlook for Arcellx Inc: Buy Rating Backed by Strategic Positioning and Promising CAR T-cell Therapy
10d ago
ACLX
Arcellx Reports Promising Phase 2 Study Results
Premium
Company Announcements
Arcellx Reports Promising Phase 2 Study Results
13d ago
8K
ACLX
Promising Clinical Data and Favorable Safety Profile Drive Buy Rating for Arcellx Inc
Premium
Ratings
Promising Clinical Data and Favorable Safety Profile Drive Buy Rating for Arcellx Inc
13d ago
ACLX
Arcellx Inc’s Promising Future: Buy Rating Backed by Strong Efficacy, Safety, and Strategic Partnerships
Premium
Ratings
Arcellx Inc’s Promising Future: Buy Rating Backed by Strong Efficacy, Safety, and Strategic Partnerships
13d ago
ACLX
Arcellx Inc’s Anito-cel: Promising CAR-T Therapy with Superior Safety Profile and Market Readiness
Premium
Ratings
Arcellx Inc’s Anito-cel: Promising CAR-T Therapy with Superior Safety Profile and Market Readiness
13d ago
ACLX
Arcellx Inc’s Promising iMMagine-1 Study and Strategic Plans Justify Buy Rating and $112 Price Target
Premium
Ratings
Arcellx Inc’s Promising iMMagine-1 Study and Strategic Plans Justify Buy Rating and $112 Price Target
14d ago
ACLX
Optimistic Buy Rating for Arcellx Inc: Promising Anito-cel Therapy and Strategic Advancements
Premium
Ratings
Optimistic Buy Rating for Arcellx Inc: Promising Anito-cel Therapy and Strategic Advancements
14d ago
ACLX
More ACLX News >

ACLX News on the Web

Arcellx Inc (ACLX) Gets a Buy from Piper Sandler
TipRanks News
Neutral
Canaccord Genuity Reaffirms Their Buy Rating on Arcellx Inc (ACLX)
TipRanks News
Neutral
Arcellx’s Anito-cel Achieves 96% Response Rate in Tough-to-Treat Multiple Myeloma: Phase 2 Data Impress at 15.9 Months
Market Chameleon
Neutral
Why Arcellx, Inc.’s (ACLX) Stock Is Up 13.57%
AAII
Neutral
Arcellx Inc (ACLX) Receives a Buy from Canaccord Genuity
TipRanks News
Neutral
Kelonia data too early to read to Gilead, Arcellx's anito-cel, says BMO Capital
The Fly
Neutral
Citi says Arcellx weakness on 'highly preliminary' Kelonia data an overreaction
The Fly
Neutral
Arcellx weakness on competitive worries 'overdone,' says Guggenheim
The Fly
Neutral

News Score - Last 7 Days

Neutral
ACLX
Sector Average
Media Buzz
This Week2 articles
Weekly Average2 articles
News Sentiment
This Week50%
Sector Average56%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is ACLX’s Media Buzz Sentiment?
2 articles about ACLX were published this week. In an average week, 2 articles are published.
    What is ACLX’s weekly average amount of articles?
    In an average week, 2 articles about ACLX are published.
      What is ACLX’s News Sentiment?
      50% of articles about ACLX were positive this week, compared to its sector average of 56%.
        Healthcare Stocks that are Trending in the News
        CYTKCytokinetics
        TXG10x Genomics
        ANIPANI Pharmaceuticals
        HIKHikma Pharmaceuticals
        PCSAProcessa Pharmaceuticals
        Showing the stocks with the most bullish news sentiment over the past week